Leukemia
Showing NaN - NaN of 108
Chronic Myelomonocytic Leukemia, Leukemia Trial in United States (Ruxolitinib)
Active, not recruiting
- Chronic Myelomonocytic Leukemia
- Leukemia
-
Tampa, Florida
- +4 more
Nov 11, 2022
Validation for Early Cancer Detection and Minimal Residual
Recruiting
- Brain Cancer
- +19 more
-
Duarte, California
- +6 more
Nov 10, 2022
Collecting and Storing Tissue From Young Patients With Cancer
Recruiting
- Acute Lymphoblastic Leukemia
- +13 more
- Cytology Specimen Collection Procedure
- Laboratory Biomarker Analysis
-
Birmingham, Alabama
- +68 more
Aug 4, 2022
Hematopoietic and Lymphoid System Tumor, Leukemia, Lymphoma Trial in Canada, United States (procedure, biological, other)
Active, not recruiting
- Hematopoietic and Lymphoid System Neoplasm
- +3 more
- Allogeneic Hematopoietic Stem Cell Transplantation
- +3 more
-
Birmingham, Alabama
- +42 more
Jul 20, 2022
Leukemia, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Worldwide (ibrutinib, venetoclax, Placebo)
Leukemia Trial in United States (cytarabine, idarubicin, pravastatin sodium)
Leukemia Trial in Cleveland (Melphalan, Thiotepa, Fludarabine)
Recruiting
- Leukemia
- Melphalan
- +3 more
-
Cleveland, OhioUniversity Hospitals Seidman Cancer Center, Case Comprehensive C
Jan 24, 2022
Leukemia, Lymphoma Trial in United States (biological, drug, procedure)
Active, not recruiting
- Leukemia
- Lymphoma
- rituximab
- +7 more
-
Duarte, California
- +24 more
Aug 16, 2021
Chronic Myeloproliferative Disorders, Leukemia, MDS Trial in Cleveland (ascorbic acid, arsenic trioxide, dexamethasone)
Completed
- Chronic Myeloproliferative Disorders
- +3 more
- ascorbic acid
- +3 more
-
Cleveland, Ohio
- +1 more
Jul 23, 2020
Brain and CNS Tumors, Chronic Myeloproliferative Disorders, Leukemia Trial in Detroit, Cleveland, Philadelphia (educational
Completed
- Brain and Central Nervous System Tumors
- +8 more
- educational intervention
-
Detroit, Michigan
- +3 more
Jul 23, 2020
Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial in Cleveland (biological, drug, procedure)
Completed
- Chronic Myeloproliferative Disorders
- +5 more
- anti-thymocyte globulin
- +5 more
-
Cleveland, OhioCase Medical Center, University Hospitals Seidman Cancer Center,
Jul 23, 2020
Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial in Cleveland (biological, drug, procedure)
Completed
- Chronic Myeloproliferative Disorders
- +5 more
- anti-thymocyte globulin
- +7 more
-
Cleveland, OhioIreland Cancer Center at University Hospitals Case Medical Cente
Jul 23, 2020
Leukemia Trial in United States (Azacitidine (AZA) Days 1 - 3, Decitabine (DAC), Best Supportive Care (BSC))
Active, not recruiting
- Leukemia
- Azacitidine (AZA) Days 1 - 3
- +3 more
-
Tampa, Florida
- +5 more
Jul 21, 2020
Leukemia Trial in Canada, United States (rituximab, fludarabine phosphate)
Terminated
- Leukemia
- rituximab
- fludarabine phosphate
-
Anniston, Alabama
- +386 more
Apr 9, 2020
Leukemia Trial in Canada, United States (biological, drug, other, procedure)
Completed
- Leukemia
- anti-thymocyte globulin
- +10 more
-
Birmingham, Alabama
- +51 more
Apr 7, 2020
Leukemia, MDS Trial in Los Angeles, Tampa, Cleveland (azacitidine, lenalidomide)
Completed
- Leukemia
- Myelodysplastic Syndromes
-
Los Angeles, California
- +2 more
Sep 18, 2018
Leukemia Trial in Durham, Cleveland (Gemcitabine Hydrochloride, Mitoxantrone Hydrochloride)
Terminated
- Leukemia
- Gemcitabine Hydrochloride
- Mitoxantrone Hydrochloride
-
Durham, North Carolina
- +1 more
Jan 24, 2018
Caregiver Support in Coping of UndergoingDonor Bone Marrow
Completed
- Chronic Myeloproliferative Disorders
- +6 more
- psychosocial assessment and care
-
Cleveland, OhioCleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
Jan 25, 2018